Encompass Health Corporation Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Encompass Health Corporation stock issued during period, value, conversion of convertible securities for the quarter ending 2020-12-31 was $0.00.
- Encompass Health Corporation stock issued during period, value, conversion of convertible securities for the quarter ending 2020-09-30 was $0.00.
- Encompass Health Corporation stock issued during period, value, conversion of convertible securities for the quarter ending 2020-06-30 was $0.00.
- Encompass Health Corporation stock issued during period, value, conversion of convertible securities for the quarter ending 2020-03-31 was $46.30M.
- Encompass Health Corporation stock issued during period, value, conversion of convertible securities for fiscal 2020 was $46.30M.
- Encompass Health Corporation stock issued during period, value, conversion of convertible securities for fiscal 2017 was $328.20M.
- Encompass Health Corporation stock issued during period, value, conversion of convertible securities for fiscal 2015 was $93.20M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $46.30M 10-K · filed 2023-02-27 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | |
| 2020-03-31 | $46.30M 10-Q · filed 2021-05-04 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $328.20M 10-K · filed 2019-02-27 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $93.20M 10-K · filed 2018-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |